Midgard Science

Kyinno Bio

Beijing, China kyinno.com

From their website, Nov 2026

Work here? Claim this listing

About

Kyinno Bio is a preclinical contract research organization serving biotechnology and pharmaceutical clients. It provides in vitro and in vivo pharmacology, cell line engineering, antibody discovery, and target identification services from Beijing, China, with a business hub in Boston, USA.

Services

  • In vitro services

    Performs cell-based and biochemical in vitro studies for oncology and immunology research, including functional assays and target engagement studies.

    Assays & in vitro testing

  • Cell proliferation assay

    Measures compound effects on cell growth and viability using readouts such as CellTiter-Glo, CellCyte, BrdU, and flow cytometry.

    Assays & in vitro testing

  • MegaScreen cell panel screening

    Screens compounds across a panel of human cancer cell lines for hit identification, lead optimization, and biomarker development.

    Assays & in vitro testing

  • In vivo services

    Offers in vivo pharmacology models for preclinical evaluation, including xenograft, humanized mouse, syngeneic, orthotopic, subcutaneous, and metastasis models.

    Assays & in vitro testing

  • Antibody discovery services

    Provides antibody discovery workflows including common light chain, nanobody discovery, AI-based antibody engineering, and off-target screening.

    Assays & in vitro testing

  • Multispecific antibody development platform

    Develops bispecific, trispecific, and nanobody-based antibodies using proprietary gene-edited mouse platforms.

    Assays & in vitro testing

  • AI-based antibody development platform

    Uses an AI platform to predict antigen-antibody structures and binding affinities, screen antibody sequence libraries, and support affinity maturation.

    Assays & in vitro testing

  • Genetically engineered cell lines

    Develops and supplies engineered cell lines for disease, therapy, and biological process studies.

    Cell line development

  • Drug combination services

    Evaluates in vitro and in vivo combination studies for drug development programs.

    Assays & in vitro testing

Turnaround
2 - 14 day Standard Assay Window
What to send
Custom assays · Custom antibodies · Cell lines · In vivo model requests

Capabilities

Assays and studies
Antibodies · In vivo · Rodent models · Bispecifics · ELISA · Flow cytometry · Cell proliferation · Cell viability · Cell panel screening · Immuno-oncology assay · ADCC · ADCP
4 moreFACS binding assay · Internalization assay · 3D organoid culture · Immune cell assay
Scale and capacity
3000+ engineered cell lines · 5000-antibody specificity screening MPSA-AB5000 panel · Over 700 sequenced and certified human cancer cell lines · 100+ validated assay platforms · 6000+ cell lines available · 5-floor, 5000m² laboratory · 130 professionals · Over 1,000 partners
Therapeutic areas
Oncology · Immunology · Cancer drug discovery · Cancer drug development

Instruments and platforms

  • CellTiter-Glo
  • CellCyte
  • BrdU
  • Flow cytometry
  • Digital PCR
  • Mass spectrometry

Modalities and species

Modalities
Small molecule · Antibody · Bispecific · ADC · Cell therapy
Species and models
Human cancer cell lines · PBMC humanized mouse · Syngeneic mouse · Orthotopic model · Subcutaneous model · Metastasis model · Ba/F3 xenograft model · Gene-editing xenograft model · Luciferase tumor model

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    As listed: GLP-Aligned QC; GLP-Aligned Protocols

Company

Type
CRO
Founded
2017
Team
130 professionals
Quality
GLP-Aligned QC · GLP-Aligned Protocols

Locations

Address
3 Gill Street, suite 100, Woburn, MA, 01801
Sites
Beijing, China · Woburn, MA, USA
Serves
global

Similar labs

Work here? Claim this listing